|Bid||413.40 x 1300|
|Ask||413.59 x 800|
|Day's range||407.60 - 415.94|
|52-week range||185.52 - 420.76|
|Beta (5Y monthly)||1.50|
|PE ratio (TTM)||7.60|
|Forward dividend & yield||8.00 (1.97%)|
|Ex-dividend date||31 Aug 2021|
|1y target est||N/A|
DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that Goldman Sachs (NYSE:GS) recognized DiscGenics Chairman and CEO Flagg Flanagan as one of the 100 Most Intriguing Entrepreneurs of 2021 at its Builders + Innovators Summit in Healdsburg, California.
NEW YORK, October 18, 2021--Goldman Sachs One Million Black Women today announced a new partnership with Echoing Green to accelerate the impact of Black women social entrepreneurs through its world-renowned Fellowship program. Goldman Sachs Foundation will provide Echoing Green with a $1 million grant to develop a new cohort of Fellows who are leading programs to positively impact and radically transform the futures of Black women and girls across the U.S.
Goldman Sachs (NYSE:GS) is recognizing Daniel Hawkins, CEO of Avail Medsystems, as one of the 100 Most Intriguing Entrepreneurs of 2021 at its Builders + Innovators Summit in Healdsburg, California.